Stromal targeted therapy in bone metastatic prostate cancer： promise delivered  

作　　者：Oliver Sartor William Goeckeler Oyvind Bruland 

机构地区：[1]Departments of Medicine and Urology, Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA 70112, USA [2]Whitehouse Station, NJ 08889, USA [3]Faculty of Medicine, University of Oslo and Department of Oncology, Norwegian Radium Hospital, Oslo 0310, Norway

出　　处：《Asian Journal of Andrology》2011年第6期783-784,共2页亚洲男性学杂志（英文版）

摘　　要：The ability of epithelial neoplasms to evade both hormonal and cytotoxic therapies is self-evident as the common carcinomas （lung, stomach, breast, colon and prostate） at their metastatic stage are rarely curable with current therapies. Though the precise reasons for incurability are debated,The ability of epithelial neoplasms to evade both hormonal and cytotoxic therapies is self-evident as the common carcinomas （lung, stomach, breast, colon and prostate） at their metastatic stage are rarely curable with current therapies. Though the precise reasons for incurability are debated,

分 类 号：Q78[生物学—分子生物学] S317[农业科学—作物栽培与耕作技术]